Affiliation:
1. From the Departments of Diagnostic Radiology, Nuclear Medicine, Radiation Oncology, Medical Oncology, Pathology, and Otorhinolaryngology and Molecular Imaging Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan, Republic of China
Abstract
Purpose To assess the clinical usefulness of [18F]fluorodeoxyglucose positron emission tomography ([18F]FDG PET) as well as computed tomography (CT) or magnetic resonance imaging (MRI) in oral squamous cell carcinoma (SCC) patients with palpably negative neck. Patients and Methods In total, 134 oral SCC patients with palpably negative neck were prospectively evaluated with [18F]FDG PET, CT/MRI, and their visual correlation. Histopathologic analysis was used as the gold standard for assessment of these imaging techniques. Results Thirty-five (26.1%) of our 134 patients were found to have neck metastases. On a level-by-level basis, the sensitivity of [18F]FDG PET for nodal metastases was two-fold higher than that of CT/MRI (41.2% v 21.6%, respectively; P = .021). Visual correlation of [18F]FDG PET and CT/MRI yielded slightly higher sensitivity and specificity than [18F]FDG PET alone (47.1% v 41.2%, P = .25; 98.0% v 96.8%, P = .125, respectively). On a patient-by-patient basis, the sensitivity of [18F]FDG PET for neck metastases was 51.4% and increased to 57.1% after visual correlation with CT/MRI. The probabilities of occult neck metastasis after using [18F]FDG PET were 6.7% in T1 tumors, 10.8% in T2 tumors, 13.3% in T3 tumors, and 25% in T4 tumors and decreased to 3.3% in T1 tumors and to 9.2% in T2 tumors after visual correlation with CT/MRI. Conclusion [18F]FDG PET was superior to CT/MRI for detecting palpably occult neck metastasis of oral SCC. Because [18F]FDG PET could reduce the probability of occult neck metastasis to less than 15% in T1 to T3 tumors, it should be indicated for evaluation of these subpopulations.
Publisher
American Society of Clinical Oncology (ASCO)
Reference30 articles.
1. Snow GB, Patel P, Leemans CR, et al: Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 249:187,1992-194,
2. Use of Decision Analysis in Planning a Management Strategy for the Stage NO Neck
3. Cervical lymph node metastasis: assessment of radiologic criteria.
4. Friedman M, Toriumi DM, Mafee MF, et al: The role of computed tomographic scanning in evaluating the clinically negative neck, in Fee WE, Goepfert H, Johns ME, et al (eds): Head and Neck Cancer (vol 2) . Toronto, Ontario, Canada, Decker, pp 138,1990-144
5. Computed tomography of the clinically negative neck
Cited by
218 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献